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Abstract
Background: The plasticity region of Helicobacter pylori (H. pylori) is a large chromosomal segment containing
strain-specific genes. The prevalence of the plasticity region genes of the H. pylori strains in China remains
unknown. The aim of this study was to examine the status of these genes and to assess the relationship between
the genes and the diseases caused by H. pylori infection.
Methods: A total of 141 strains were isolated from patients with chronic active gastritis (CAG), peptic ulcer disease
(PUD) and gastric carcinoma (GC). The prevalence of jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951 was determined
using PCR, and the results were analyzed using the chi-squared test.
Results: The prevalence rates of jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951 in the H. pylori strains were 42.55, 51.06,
20.57, 56.03 and 63.12 %, respectively. The prevalence rates of jhp0940 were similar in the isolates from the CAG, PUD
and GC patients, and there was no association between the jhp0940 status and any of the diseases. In contrast, the
prevalence rates of jhp0945, jhp0947, jhp0949 and jhp0951 were significantly higher in the PUD and GC isolates than in
the CAG isolates (p < 0.01). A univariate analysis showed that jhp0945, jhp0947, jhp0949 and jhp0951 increased the
risk of PUD, while only jhp0951 was significantly associated with PUD in the multivariate analysis (p = 0.0149). The
jhp0945-positive isolates were significantly associated with an increased risk for GC (p = 0.0097).
Conclusion: The plasticity region genes are widely distributed in Chinese patients, and a high prevalence of
these genes occurs in more serious diseases. Therefore, jhp0951 status is an independent factor associated with
the development of PUD, and jhp0945 may predict the future development of GC in patients with CAG and is
considered to be the best candidate disease marker for H. pylori-related diseases.
Background
H. pylori is the major cause of chronic gastritis, peptic
ulcer disease, gastric carcinoma and mucosa-associated
lymphoid tissue lymphoma [1, 2]. The majority of in-
fected individuals remain asymptomatic throughout
their lifetime, and only approximately 15 % develop gas-
troduodenal diseases. Variations in the clinical outcomes
of these diseases have been attributed to differences in
environmental factors, bacterial strains and host genetics
[3, 4]. A number of bacterial virulence factors that are
associated with these diseases have been described for
H. pylori, such as the cag pathogenicity island (cag
PAI) [5, 6].
A comparison of the genomes of two H. pylori strains
revealed that in addition to the cag PAI, a large region of
approximately 45 kb in strain J99 and 68 kb in strain
26695 is present in both strains and has been termed the
“plasticity region” [7, 8] . Up to 50 % of the strain-
specific genes transferred from other species are located
in the plasticity region [9]. Whether these strain-specific
genes influence the severity of different diseases or the
biological functions of the ORFs in the plasticity region
still remains unknown. Recent studies have revealed that
the jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951
genes from H. pylori are associated with an increased
risk for gastroduodenal diseases [3, 9–11]. In a Brazilian
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study, the jhp0947 gene was found to be involved in the
development of duodenal ulcers (DUs) and GC [11]. In
addition, Romo-González et al. found that jhp0951 is
also associated with DUs [9]. In China, the number of H.
pylori infections has exceeded 60 %, and the high-risk
incidence of GC poses a serious health and economic
burden. Moreover, there are no reports discussing the
prevalence of these genes or the relationship between
the genes and the severity of the clinical outcomes of
the abovementioned diseases in China. The aim of this
study was to assess the prevalence of jhp0940, jhp0945,
jhp0947, jhp0949 and jhp0951 and to determine their as-
sociation with H. pylori-related diseases.
Methods
Strains
A total of 141 H. pylori strains were selected from the H.
pylori strain bank of China at the National Institute for
Communicable Disease Control and Prevention, Chinese
Center for Disease Control and Prevention. A total of 40
strains were isolated from patients in Heilongjiang (HLJ)
Province (located in northern China), and another 101
strains were isolated from patients from Jiangxi (JX)
Province (located in southeast China). These strains
were related with CAG only (n = 58), PUD (n = 45) or
GC (n = 38). Two strains with fully sequenced genomes,
including strain 26695, which was isolated from a gastri-
tis patient, and strain J99, which was isolated from a pa-
tient with a duodenal ulcer, were used as controls. This
study was approved by the Ethics Committee of National
Institute for Communicable Disease Control and Pre-
vention, Chinese Center for Disease Control and Pre-
vention. The written informed consent was obtained
from all patients.
Culture and extraction of genomic DNA
The strains stored in brain heart infusion in −80 °C were
recovered on Columbia agar plates (Oxoid) supple-
mented with 5 % fresh defibrinated sheep blood and
kept under microaerophilic conditions (5 % O2, 10 %
CO2 and 85 % N2) at 37 °C for 3 days. Colonies display-
ing typical H. pylori morphology were selected and iden-
tified by Gram staining and urease, oxidase, and catalase
activity testing. The bacterial cells on chocolate agar
plate were washed twice with phosphate buffer saline
(PBS, pH7.5) and centrifuged at 5000 rpm for 10 min.
The chromosomal DNA was extracted using the
QIAamp DNA Mini Kit (Qiagen, Germany) according to
the manufacturer’s instructions.
Determination of the jhp0940, jhp0945, jhp0947, jhp0949
and jhp0951 status via PCR
The status of the genes was determined via PCR using
the primer pairs shown in Table 1. The amplification of
the genes was performed in a volume of 25 μl containing
25 pmol of both forward and reverse primers. The PCR
conditions were 95 °C for 5 min, followed by 35 cycles
of 95 °C for 45 s, 52 °C for 45 s, and 72 °C for 45 s, and
finally 72 °C for 5 min. Two primer sets were used for
the jhp0940 gene, and when the PCR using one pair was
positive, the jhp0940 status was determined to be posi-
tive. The status of the genes was positive in strain J99
and negative in strain 26695.
Statistical analysis
The prevalence rates of all five genes were evaluated.
The association between each genotype and the clinical
outcomes were quantified using the chi-squared test. A
probability (p) value equal to or less than 0.05 was con-
sidered to be statistically significant, and a value of 0.001
or less was considered to be highly significant. Univari-
ate analysis and a multivariate logistic regression model
were used to calculate the odds ratios (ORs) of the clin-
ical outcomes using SAS 9.3.
Results
Distribution of the jhp0940, jhp0945, jhp0947, jhp0949 and
jhp0951 genes
The prevalence rates of jhp0940, jhp0945, jhp0947,
jhp0949 and jhp0951 in the tested H. pylori were
42.55 % (60/141), 51.06 % (72/141), 20.57 % (29/141),
56.03 % (79/141) and 63.12 % (89/141), respectively
(Table 2).
Geographic variation of plasticity region genes
The results were divided into two groups based on
their geographic variation. By comparing the results of
the strains from HLJ Province and JX Province, we
Table 1 The primer sequences for the five genes
Primer
name
Primer sequence (5′-3′) Product size Reference
jhp0940-1 F5′-GAAATGTCCTATACCAATGG 591 bp [3]
R5′-CCTAAGTAGTGCATCAAGG
jhp0940-2 F5′-ATGCCAACCATTGATTTTACTTTT 978 bp [12]
R5′-TTATCGTCTACGCTTAGGTGTG
jhp0945 F5′-CAATGCGACTAACAGCATAG 1028 bp [3]
R5′-CGCATTTGCTGTCATCTTTG
jhp0947 F5′-GATAATCCTACGCAGAACG 611 bp [3]
R5′-GCTAAAGTCATTTGGCTGTC
jhp0949 F5′-TTCAAAAAGTCCCCGAAATG 235 bp [10]
R5′-GGATGTCCTGGCATGTCTCT
jhp0951 F5′-ATGCGTGGCTAAGCGATACT 243 bp [19]
R5′-GACCCAACGCTCTTGAAGTT
The primer sequences used for the five genes were the same as the
references. There were two pairs of primers used for jhp0940
F, forward primer sequence; R, reverse primer sequence
Gong et al. BMC Gastroenterology  (2015) 15:115 Page 2 of 5
found no significant differences in the prevalence of
jhp0940 (40 %, 16/40 and 43.56 %, 44/101, respect-
ively, p = 0.699), jhp0945 (42.5 %, 17/40 and 54.46 %,
55/101, p = 0.201), jhp0947 (10 %, 4/40 and 24.75 %,
25/101, p = 0.051), jhp0949 (52.5 %, 21/40 and
57.43 %, 58/101, p = 0.595), or jhp0951 (57.5 %, 23/40
and 65.35 %, 66/101, p = 0.384).
Plasticity region genes and diseases
The prevalence rates of jhp0940 in the strains from the
CAG, PUD and GC patients were 34.48 % (20/58), 48.89 %
(22/45) and 47.37 % (18/38), respectively, and there were
no differences between the three diseases. The prevalence
rates of jhp0945 in the isolates from the patients with PUD
(62.22 %, 28/45) and GC (73.68 %, 28/38) were significantly
higher than from the CAG patients (27.59 %, 16/58;
p = 0.0004 and p < 0.0001, respectively). The jhp0947
gene occurred in only 4 (6.89 %) of the strains isolated
from the CAG patients, and the occurrence was much
lower than in the PUD and GC patients (33.33 %, 15/45
and 26.32 %, 10/38; p = 0.0006 and p = 0.0084, respect-
ively). The prevalence of jhp0949 was similar (68.89 %, 31/
45 and 65.79 %, 25/38) in the PUD and GC isolates and
was much higher than that in the CAG patients (39.66 %,
23/58; p = 0.0032 and p = 0.0123, respectively). For
jhp0951, the prevalence rate in the PUD patients was
higher than that in the CAG patients (77.78 %, 35/45 and
53.45 %, 31/58, respectively; p = 0.0107); however, there
was no difference between GC and CAG.
The relationship between jhp0940, jhp0945, jhp0947,
jhp0949 and jhp0951
The status of all of the genes showed that they are sig-
nificantly associated with each other (Table 3). The sta-
tus of jhp0945 was associated with jhp0949 (p = 0.009)
and jhp0951 (p = 0.022). All of the jhp0947-positive iso-
lates possessed jhp0949, and both were significantly
associated with jhp0951 (p = 0.0008 and p < 0.0001,
respectively).
When combining the five genes together, the major-
ity of the genotypes were all negative or all positive
(the −/−/−/−/- genotype or the +/+/+/+/+ genotype,
12.06 %, 17/141). The rates of the all-positive genotypes
were 15.79 % (6/38), 20 % (9/45) and 3.45 % (2/58) in the
isolates from the patients with GC, PUD and CAG only,
respectively. In contrast, the rates of the all-negative
genotypes were 5.26 % (2/38), 2.22 % (1/45) and
24.14 % (14/58) for GC, PUD, and CAG, respectively.
The relationship between the gene status and the clinical
outcomes
A univariate analysis showed that there was no signifi-
cant association between the jhp0940 status and the
selected diseases (Table 4), but the status of jhp0945,
jhp0947, jhp0949 and jhp0951 was significantly associ-
ated with a lower risk for CAG (odds ratio (OR), [95 %
confidence interval (CI)], 0.176 [0.081 to 0.381]; 0.116
[0.035 to 0.389]; 0.300 [0.145 to 0.623] and 0.445 [0.214
to 0.928], respectively). On the converse, they were also
related to an increased risk for PUD (OR [95 % CI],
2.306 [1.08 to 4.927]; 2.835 [1.191 to 6.751], 2.452 [1.126
to 5.336] and 2.825 [1.226 to 6.51], respectively). More-
over, only the jhp0945-positive isolates were associated
with an increased risk for GC (OR, 5.9259; 95 % CI,
1.267 to 27.714).
A multivariate analysis, including age and jhp0940,
jhp0945, jhp0947, jhp0949 and jhp0951 status, was per-
formed to determine the factors that were related to the
Table 2 The prevalence of the five genes in the CAG, PUD and
GC isolates
Noa (%) found
Gene CAGb PUDc GCd Totale
HLJ (n = 20) HLJ (n = 9) HLJ (n = 11)
JX (n = 38) JX (n = 36) JX (n = 27)
HLJf jhp0940 6 (30 %) 3 (33.33 %) 7 (63.64 %) 16 (40 %)
n = 40
jhp0945 5 (25 %) 4 (44.44 %) 8 (72.73 %) 17 (42.5 %)
jhp0947 2 (10 %) 0 2 (18.18 %) 4 (10 %)
jhp0949 8 (40 %) 7 (77.78 %) 6 (54.55 %) 21 (52.5 %)
jhp0951 11 (55 %) 6 (66.67 %) 6 (54.55 %) 23 (57.5 %)
JXg jhp0940 14 (36.84 %) 19 (52.78 %) 11 (40.74 %) 44 (43.56 %)
n = 101
jhp0945 11 (28.95 %) 24 (66.67 %) 20 (74.07 %) 55 (54.46 %)
jhp0947 2 (5.26 %) 15 (41.67 %) 8 (29.63 %) 25 (24.75 %)
jhp0949 15 (39.47 %) 24 (66.67 %) 19 (70.37 %) 58 (57.43 %)
jhp0951 20 (52.63 %) 29 (80.56 %) 17 (62.96 %) 66 (65.35 %)
The positive rates of each gene in the CAG, PUD and GC patients from HLJ
and JX Provinces
aNo the number of positive isolates
bCAG chronic active gastritis
cPUD peptic ulcer disease
dGC gastric carcinoma
eTotal the total positive rate of each gene
fHL Heilongjiang Province, China
gJX Jiangxi Province, China
Table 3 The relationship between the different plasticity region
genes
Relationship (coefficient valuea/p value)
gene jhp0945 jhp0947 jhp0949 jhp0951
jhp0940 0.183/0.03 0.236/0.005 0.184/0.029 0.182/0.031
jhp0945 — 0.358/<0.0001 0.219/0.009 0.193/0.022
jhp0947 — — 0.415/<0.0001 0.280/0.0008
jhp0949 — — — 0.478/<0.0001
The coefficient value for assessing the association between each pair of genes.
A p value of 0.001 or less was considered to be highly significant
The coefficient valuea was analyzed using Fisher’s test
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clinical outcomes of the selected diseases (Table 5). The
jhp0945 status for GC and the jhp0951 status for PUD
significantly increased the risk of a clinical outcome. In
contrast, the jhp0945 or jhp0949 status significantly de-
creased the risk for CAG (OR [95 % CI]: 0.214 [0.099 to
0.466]; 0.373 [0.172 to 0.807], respectively). Age signifi-
cantly decreased the risk of CAG and PUD (OR [95 % CI]:
0.964 [0.937 to 0.992]; 0.963 [0.937 to 0.991], respectively),
while it increased the risk for GC (1.098 [1.059 to 1.139]).
Discussion
The plasticity region is a recently identified locus found
in the chromosome of H. pylori strains J99 and 26695
that displays similar characteristics to pathogenicity
islands [7, 8]. The majority of the H. pylori strain-
specific genes that are transferred from other species are
located in the plasticity region [9, 12, 13]. The genes
present in the plasticity region have been highlighted as
potential pathogenic markers and may account for the
differences in the H. pylori strain virulence, resulting in
various clinical outcomes.
The jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951
genes, which are specific for strain J99, have recently
been reported to be associated with H. pylori-related dis-
eases and are potential markers for the risk of gastro-
intestinal diseases [10]. Because of their geographic
variation, the relationship between these genes and the
severity of certain diseases has been discussed, but the
results are often not in agreement. The prevalence of
these genes and their relationship with certain diseases
in China is currently unknown; therefore, we examined
the distribution of these virulence markers and their re-
lationship to the clinical outcomes of patients infected
with H. pylori.
Previous study found that there were no significant as-
sociations between the gastroduodenal diseases and the
status of jhp0940, jhp0945 and jhp0949 in East Asia
strains [10]. Yakoob et al. demonstrated that jhp0940
and jhp0947 in Pakistan strains were associated with GC
and PUD [14]. In our study, there was no association be-
tween jhp0940 and diseases. The positive rates of
jhp0945, jhp0947, jhp0949 and jhp0951 were much
higher in PUD, and there was a significant association
between the genes. However, the multivariate analysis
showed that only jhp0951 was independently associated
with the development of PUD in our study. Jhp0951,
which encodes an integrase from the XerCD family, is
involved in the response to acidic environments [15]. In
DUs, acid secretion increases, causing the mucosa to be
continuously exposed to a low pH, which is consistent
with our results [9]. As the virulence genes were associ-
ated with each other in our study, the strong linkage of
jhp0945, jhp0947 and jhp0949 with PUD may be due to
the significant association between jhp0951 and PUD.
We also speculate that all of these factors act synergis-
tically in causing damage to the host.
It is well known that the development of GC is marked
by a slow progression that begins with H. pylori-induced
chronic superficial gastritis, which then progresses to atro-
phic gastritis, intestinal metaplasia, dysplasia and eventu-
ally GC [16, 17]. In our study, the multivariate analysis
showed that the only independent virulence gene that
Table 4 The relationship between each gene and the clinical outcomes
CAGa PUDb GCc
gene ORd 95 % CIe p OR 95 % CI p OR 95 % CI p
jhp0940 0.488 0.235–1.013 0.054 1.449 0.694–3.026 0.323 1.822 0.734–4.523 0.196
jhp0945 0.176 0.081–0.381 <0.0001 2.306 1.08–4.927 0.031 3.542 1.362–9.209 0.009
jhp0947 0.116 0.035–0.389 0.0005 2.835 1.191–6.751 0.019 2.307 0.765–6.952 0.134
jhp0949 0.300 0.145–0.623 0.0012 2.452 1.126–5.336 0.024 2.067 0.812–5.26 0.128
jhp0951 0.445 0.214–0.928 0.031 2.825 1.226–6.51 0.015 1.008 0.403–2.517 0.987
The univariate analysis showing the association between each gene status and the indicated disease
aCAG chronic active gastritis




Table 5 A multivariate analysis of the risk for CAG, PUD and GC
based on age and the status of all five genes
Disease Parameter ORd 95 % CIe p value
CAGa jhp0945 0.214 0.099–0.466 0.0001
jhp0949 0.373 0.172–0.807 0.0123
age 0.964 0.937–0.992 0.0111
PUDb jhp0951 2.821 1.224–6.499 0.0149
age 0.963 0.937–0.991 0.0089
GCc jhp0945 3.460 1.351–8.865 0.0097
age 1.098 1.059–1.139 <0.0001
aCAG chronic active gastritis




Gong et al. BMC Gastroenterology  (2015) 15:115 Page 4 of 5
increased the risk of GC was jhp0945, indicating a signifi-
cant association between the two. However, the jhp0945
status showed a negative association with CAG (Table 5),
which conflicts with the process of GC development. In
our study, we speculate that the majority of the individuals
with CAG do not carry the jhp0945 gene, while the few
jhp0945-positive individuals potentially develop GC due
to a combination of the bacteria, the host and other envir-
onmental factors, which is consistent with the fact that of
the H. pylori-infected individuals, 80–90 % have clinically
asymptomatic gastritis, while only 1–2 % develop GC [18].
Jhp0945-positive isolates may be more likely to develop
severe diseases, and jhp0945 status may be a risk indicator
for GC development. Additional prospective studies are
still necessary to further confirm our speculations.
Conclusions
In conclusion, this was the first study in China to evalu-
ate the relationship between plasticity region genes and
clinical disease outcomes. We found that jhp0951 status
is an independent factor for discriminating PUD and
may influence the association of other virulence factors
with certain diseases. Jhp0945 may predict the future de-
velopment of GC in patients with CAG and is consid-
ered to be the best candidate disease marker for H.
pylori-related diseases.
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